Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Fibulin 3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA520761
Description
A suggested positive control is Hela cell lysate. PA5-20761 can be used with blocking peptide PEP-0875.
This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.
Specifications
Fibulin 3 | |
Polyclonal | |
Unconjugated | |
EFEMP1 | |
DHRD; DRAD; EFEMP1; EGF containing fibulin like extracellular matrix protein 1; EGF containing fibulin-like extracellular matrix protein 1; EGF-containing fibulin-like extracellular matrix protein 1; epidermal growth factor-containing fibulin-like extracellular matrix protein 1; extracellular protein S1-5; FBLN3; FBNL; FIBL-3; Fibrillin-like protein; Fibulin-3; FLJ35535; MGC111353; MLVT; MTLV; S1-5; T16 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
2202 | |
Maintain refrigerated at 2°C to 8°C for up to 3 months. For long term storage store at -20°C | |
Liquid |
Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q12805 | |
EFEMP1 | |
A 19 amino acid peptide near the carboxy terminus of human Fibulin 3. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction